The PDE7A/CRE Reporter-HEK293 line contains the firefly luciferase gene under the control of CRE as well as a constitutive expression construct for human PDE7A (phosphodiesterase 7A, accession number NM_002603), both stably integrated into HEK293 cells. The luciferase expression level from the CRE reporter is used to monitor the activity of PDE7A in the cells.
Interested in screening and profiling inhibitors of PDE7A without the need to purchase and license the cell line? Check out our Cell Signaling Pathway Screening.
Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.
PDE7A overexpression reduces the level of cAMP following forskolin stimulation in PDE7A /CRE-HEK293 cells. This effect is reversed by BRL 50481, a PDE7A inhibitor
BRL50481 inhibition dose response curve in PDE7A /CRE Reporter cells
Each vial contains ~ X 106 cells in 1 ml of 10% DMSO.
Biological Activity
The cell line is validated for the induction of the expression of luciferase reporter by an inhibitor of PDE7A.
Genbank #
NM_002603
UniProt #
Q13946
Mycoplasma Testing
The cell line has been screened using the PCR-based VenorGeM Mycoplasma Detection kit (Sigma Aldrich) to confirm the absence of Mycoplasma species.
References
1. Malik, R. et al. (2008) Cloning, stable expression of human phosphodiesterase 7A and development of an assay for screening of PDE7 selective inhibitors. Appl. Microbiol. Biotechnol. 77 (5): 1167-1173.
2. Fan Chung, K. (2006) Phosphodiesterase inhibitors in airways disease. Eur. J. Pharmacol. 533(1-3):110-117.
Storage/Stability
Store in liquid nitrogen immediately upon receipt.
Instructions for Use
See data sheet for detailed culturing and assay protocol.
Applications
•Monitor Thuman PDE7A activity •Screen for activators or inhibitors of PDE7A
Shipping Temperature
-80°C
Notes
License Disclosure Visit bpsbioscience.com/license for the label license and other key information about this product.